Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics, Northrop Grumman to Develop, Sell Pathogen-Detection Tool for US Gov't

NEW YORK (GenomeWeb News) — US Genomics today said it will work with aerospace and defense giant Northrop Grumman to develop and market US Genomics’ biodetection technology for the Department of Homeland Security.
 
US Genomics has already received around $23 million in funding from the Homeland Security to develop a prototype of the instrument, which uses the company’s single molecule-detection technology to find “a wide range of pathogens and toxins.”
 
US Genomics said its mapping technology uses a universal reagent set to produce a “genomic signature” for each DNA sample, allowing for identification of pathogens.
 
The company said the test is sensitive enough to present “extremely low” rates of false positives. The platform does not use pathogen-specific reagents and needs no amplification, the company said.
 
The test would also enable researchers to detect species that were modified or were designed to avoid detection, US Genomics said.
 
US Genomics CEO John Canepa said the Northrop Grumman partnership is “the next logical step in moving our technology from the laboratory toward providing real protection from biological attacks.”

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.